VNDA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.90%

Insider Buying (Last 12 Months): $151,180.00

Insider Selling (Last 12 Months): $39,175.92

Vanda Pharmaceuticals Insider Trading History Chart

Vanda Pharmaceuticals Share Price & Price History

^$4.69

▲ +0.09 (1.96%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Vanda Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Mihael Hristos Polymeropoulos	CEO	Buy	10,000	$5.02	$50,200.00	2,285,731
2/28/2025	Mihael Hristos Polymeropoulos	CEO	Buy	10,000	$4.76	$47,600.00	2,361,730
2/25/2025	Mihael Hristos Polymeropoulos	CEO	Buy	10,000	$4.46	$44,600.00	2,331,730
2/21/2025	Kevin Patrick Moran	CFO	Buy	2,000	$4.39	$8,780.00	355,763
11/14/2024	Stephen Ray Mitchell	Director	Sell	5,000	$5.17	$25,850.00	44,857
7/29/2024	Kevin Patrick Moran	CFO	Sell	2,251	$5.92	$13,325.92	228,763
8/21/2023	Joakim Wijkstrom	CMO	Sell	3,724	$5.84	$21,748.16	113,816
8/10/2023	Stephen Ray Mitchell	Director	Sell	6,500	$6.05	$39,325.00	29,328
7/28/2023	Kevin Patrick Moran	CFO	Sell	2,212	$6.30	$13,935.60	120,714
6/15/2023	Kevin Patrick Moran	CFO	Sell	16,000	$6.29	$100,640.00	122,926
6/13/2023	Timothy Williams	SVP	Sell	14,600	$6.56	$95,776.00	88,913
3/2/2023	Joakim Wijkstrom	CMO	Sell	7,720	$6.23	$48,095.60	121,653
3/2/2023	Kevin Patrick Moran	CFO	Sell	7,966	$6.26	$49,867.16	144,894
3/2/2023	Mihael Hristos Polymeropoulos	CEO	Sell	22,426	$6.23	$139,713.98	1,499,440
3/2/2023	Timothy Williams	SVP	Sell	8,437	$6.24	$52,646.88	111,814
12/15/2022	Timothy Williams	SVP	Sell	8,000	$7.01	$56,080.00	87,551
12/6/2022	Kevin Patrick Moran	CFO	Sell	4,792	$10.61	$50,843.12	120,160
12/5/2022	Mihael Hristos Polymeropoulos	CEO	Sell	47,650	$10.62	$506,043.00	1,379,751
8/22/2022	Joakim Wijkstrom	CMO	Sell	3,605	$10.27	$37,023.35	96,673
7/28/2022	Kevin Patrick Moran	CFO	Sell	2,239	$10.97	$24,561.83	117,452
6/13/2022	Stephen Ray Mitchell	Director	Sell	2,700	$9.48	$25,596.00	6,515
5/31/2022	Richard W Dugan	Director	Sell	6,500	$9.85	$64,025.00	68,387

See Full Table

SEC Filings (Institutional Ownership Changes) for Vanda Pharmaceuticals (NASDAQ:VNDA)

88.14% of Vanda Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vanda Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	348,846	$1.67M	0.0%	+12.7%	0.598%
2/20/2025	Mackenzie Financial Corp	50,012	$0.24M	0.0%	N/A	0.086%
2/19/2025	Public Employees Retirement System of Ohio	89,032	$0.43M	0.0%	-16.2%	0.153%
2/18/2025	Krensavage Asset Management LLC	100,332	$0.48M	0.3%	-75.8%	0.172%
2/17/2025	Squarepoint Ops LLC	71,131	$0.34M	0.0%	+186.4%	0.122%
2/17/2025	Two Sigma Advisers LP	156,300	$0.75M	0.0%	+11.2%	0.268%
2/17/2025	Two Sigma Investments LP	199,460	$0.96M	0.0%	+94.7%	0.342%
2/17/2025	Stonepine Capital Management LLC	25,000	$0.12M	0.1%	N/A	0.043%
2/17/2025	ProShare Advisors LLC	18,815	$90K	0.0%	+32.4%	0.032%
2/17/2025	Quantinno Capital Management LP	10,012	$48K	0.0%	N/A	0.017%
2/17/2025	Millennium Management LLC	668,693	$3.20M	0.0%	+67.4%	1.147%
2/17/2025	Lazard Asset Management LLC	23,763	$0.11M	0.0%	-77.0%	0.041%
2/17/2025	Jacobs Levy Equity Management Inc.	470,726	$2.26M	0.0%	-67.1%	0.807%
2/17/2025	Deutsche Bank AG	70,169	$0.34M	0.0%	+54.6%	0.120%
2/17/2025	D. E. Shaw & Co. Inc.	304,146	$1.46M	0.0%	-45.7%	0.522%
2/17/2025	Cubist Systematic Strategies LLC	108,835	$0.52M	0.0%	+9.6%	0.187%
2/17/2025	Bridgeway Capital Management LLC	166,200	$0.80M	0.0%	-60.4%	0.285%
2/17/2025	Bank of America Corp DE	128,336	$0.62M	0.0%	+28.8%	0.220%
2/17/2025	BNP Paribas Financial Markets	72,312	$0.35M	0.0%	+16.2%	0.124%
2/17/2025	Ameriprise Financial Inc.	191,220	$0.92M	0.0%	-21.0%	0.328%
2/14/2025	Jane Street Group LLC	23,613	$0.11M	0.0%	-70.7%	0.040%
2/14/2025	Schonfeld Strategic Advisors LLC	270,541	$1.30M	0.0%	N/A	0.464%
2/14/2025	Northern Trust Corp	507,442	$2.43M	0.0%	+1.3%	0.870%
2/14/2025	Tudor Investment Corp ET AL	24,618	$0.12M	0.0%	+59.5%	0.042%
2/14/2025	Susquehanna Fundamental Investments LLC	254,845	$1.22M	0.0%	N/A	0.437%
2/14/2025	Empire Financial Management Company LLC	64,000	$0.31M	0.1%	N/A	0.110%
2/14/2025	Price T Rowe Associates Inc. MD	22,265	$0.11M	0.0%	+17.8%	0.038%
2/14/2025	Hsbc Holdings PLC	48,049	$0.23M	0.0%	+81.6%	0.082%
2/14/2025	MetLife Investment Management LLC	27,606	$0.13M	0.0%	-16.6%	0.047%
2/14/2025	Dimensional Fund Advisors LP	2,488,519	$11.92M	0.0%	+10.1%	4.268%
2/13/2025	Marshall Wace LLP	80,800	$0.39M	0.0%	N/A	0.139%
2/13/2025	Zacks Investment Management	15,471	$74K	0.0%	N/A	0.027%
2/13/2025	Jump Financial LLC	102,481	$0.49M	0.0%	+32.7%	0.176%
2/13/2025	XTX Topco Ltd	14,496	$69K	0.0%	N/A	0.025%
2/13/2025	Barclays PLC	178,368	$0.85M	0.0%	+15.6%	0.306%
2/13/2025	Kennedy Capital Management LLC	221,321	$1.06M	0.0%	-2.2%	0.380%
2/13/2025	Martingale Asset Management L P	64,809	$0.31M	0.0%	-7.4%	0.111%
2/13/2025	Renaissance Technologies LLC	3,853,799	$18.46M	0.0%	-3.9%	6.609%
2/13/2025	Federated Hermes Inc.	726,619	$3.48M	0.0%	+1.4%	1.246%
2/13/2025	Russell Investments Group Ltd.	35,375	$0.17M	0.0%	-33.9%	0.061%
2/13/2025	Wells Fargo & Company MN	33,509	$0.16M	0.0%	+28.0%	0.057%
2/12/2025	ExodusPoint Capital Management LP	31,506	$0.15M	0.0%	-74.9%	0.054%
2/12/2025	Massachusetts Financial Services Co. MA	178,847	$0.86M	0.0%	-2.9%	0.307%
2/12/2025	Trexquant Investment LP	226,676	$1.09M	0.0%	+10.9%	0.389%
2/12/2025	Geode Capital Management LLC	1,450,310	$6.95M	0.0%	+1.7%	2.487%
2/12/2025	Franklin Resources Inc.	19,780	$95K	0.0%	-64.2%	0.034%
2/12/2025	Wellington Management Group LLP	348,846	$1.67M	0.0%	+12.7%	0.598%
2/12/2025	Brandywine Global Investment Management LLC	39,390	$0.19M	0.0%	+13.9%	0.068%
2/12/2025	Norges Bank	115,000	$0.55M	0.0%	N/A	0.197%
2/12/2025	JPMorgan Chase & Co.	335,741	$1.61M	0.0%	+108.9%	0.576%
2/11/2025	Corebridge Financial Inc.	28,340	$0.14M	0.0%	-7.0%	0.049%
2/11/2025	Vanguard Group Inc.	3,506,287	$16.80M	0.0%	-3.4%	6.013%
2/11/2025	Fox Run Management L.L.C.	19,247	$92K	0.0%	-42.5%	0.033%
2/11/2025	KLP Kapitalforvaltning AS	135,400	$0.65M	0.0%	N/A	0.232%
2/11/2025	American Century Companies Inc.	300,276	$1.44M	0.0%	+2.1%	0.515%
2/11/2025	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	145,557	$0.70M	0.0%	-16.8%	0.250%
2/10/2025	Monaco Asset Management SAM	392,262	$1.88M	0.3%	+92.8%	0.673%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	819,382	$3.93M	0.0%	+4.9%	1.405%
2/6/2025	Charles Schwab Investment Management Inc.	558,446	$2.68M	0.0%	-6.3%	0.958%
2/4/2025	Los Angeles Capital Management LLC	232,081	$1.11M	0.0%	-16.2%	0.398%
2/4/2025	Bank of New York Mellon Corp	175,017	$0.84M	0.0%	-14.7%	0.300%
1/29/2025	Allspring Global Investments Holdings LLC	73,858	$0.35M	0.0%	-51.3%	0.127%
1/17/2025	SG Americas Securities LLC	25,861	$0.12M	0.0%	+26.8%	0.044%
12/26/2024	JPMorgan Chase & Co.	160,722	$0.75M	0.0%	+16.1%	0.276%
11/27/2024	Franklin Resources Inc.	55,226	$0.27M	0.0%	+8.8%	0.095%
11/20/2024	Virtu Financial LLC	21,713	$0.10M	0.0%	-66.7%	0.037%
11/19/2024	Barclays PLC	154,297	$0.72M	0.0%	+128.2%	0.265%
11/16/2024	Geode Capital Management LLC	1,425,827	$6.69M	0.0%	+7.1%	2.445%
11/15/2024	Barclays PLC	154,297	$0.72M	0.0%	+128.2%	0.265%
11/15/2024	Public Employees Retirement System of Ohio	106,232	$0.50M	0.0%	-3.6%	0.182%
11/15/2024	Krensavage Asset Management LLC	414,684	$1.95M	1.1%	-37.4%	0.711%
11/15/2024	Wellington Management Group LLP	309,651	$1.45M	0.0%	-15.3%	0.531%
11/15/2024	State Street Corp	1,165,182	$5.47M	0.0%	-3.8%	1.998%
11/15/2024	Jacobs Levy Equity Management Inc.	1,430,533	$6.71M	0.0%	-3.7%	2.453%
11/15/2024	ClearAlpha Technologies LP	60,000	$0.28M	0.1%	+50.0%	0.103%
11/14/2024	Verition Fund Management LLC	40,285	$0.19M	0.0%	+7.8%	0.069%
11/14/2024	Martingale Asset Management L P	70,009	$0.33M	0.0%	-7.3%	0.120%
11/13/2024	BNP Paribas Financial Markets	62,238	$0.29M	0.0%	+1,184.6%	0.107%
11/13/2024	FMR LLC	149,739	$0.70M	0.0%	+25.9%	0.257%
11/12/2024	Charles Schwab Investment Management Inc.	596,210	$2.80M	0.0%	+0.6%	1.023%
11/12/2024	Massachusetts Financial Services Co. MA	184,181	$0.86M	0.0%	N/A	0.316%
11/9/2024	Intech Investment Management LLC	18,014	$84K	0.0%	N/A	0.031%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	780,933	$3.66M	0.0%	+7.7%	1.340%
11/6/2024	Empowered Funds LLC	228,287	$1.07M	0.0%	+5.3%	0.392%
11/6/2024	Cornercap Investment Counsel Inc.	16,101	$76K	0.0%	-50.6%	0.028%
11/5/2024	BML Capital Management LLC	228,500	$1.07M	0.6%	-42.6%	0.392%
11/5/2024	GSA Capital Partners LLP	30,423	$0.14M	0.0%	N/A	0.052%
11/4/2024	Los Angeles Capital Management LLC	276,881	$1.30M	0.0%	-14.8%	0.475%
10/25/2024	China Universal Asset Management Co. Ltd.	11,211	$53K	0.0%	+64.0%	0.019%
10/11/2024	ORG Wealth Partners LLC	8,469	$40K	0.0%	N/A	0.015%
10/9/2024	Profit Investment Management LLC	329,822	$1.55M	1.2%	-42.3%	0.566%
10/3/2024	SG Americas Securities LLC	20,402	$96K	0.0%	+88.5%	0.035%
8/20/2024	Nantahala Capital Management LLC	1,593,516	$9M	0.5%	+57.3%	2.734%
8/15/2024	Susquehanna Fundamental Investments LLC	287,677	$1.63M	0.0%	+2.1%	0.494%
8/15/2024	Mackenzie Financial Corp	10,937	$62K	0.0%	-26.9%	0.019%
8/15/2024	AQR Capital Management LLC	75,889	$0.43M	0.0%	+181.7%	0.130%
8/14/2024	Squarepoint Ops LLC	79,030	$0.45M	0.0%	-66.5%	0.136%
8/14/2024	Marshall Wace LLP	24,504	$0.14M	0.0%	-63.2%	0.042%
8/14/2024	ProShare Advisors LLC	11,158	$63K	0.0%	-21.3%	0.019%
8/13/2024	Sei Investments Co.	395,157	$2.23M	0.0%	-23.8%	0.678%

Data available starting January 2016

See Full Table

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia. The company's pipeline products also include VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders; VHX-896, an active metabolite of iloperidone; and antisense oligonucleotide molecules. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; and VPO-227 for the treatment of secretory diarrhea disorders comprising cholera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

Today's Range

Now: $4.69

$4.57

$4.71

50 Day Range

MA: $4.66

$4.31

$5.13

52 Week Range

Now: $4.69

$3.87

$6.75

Volume

735,093 shs

Average Volume

1,138,874 shs

Market Capitalization

$273.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Vanda Pharmaceuticals?: Vanda Pharmaceuticals' top insider investors include:
Mihael Hristos Polymeropoulos (CEO)
Kevin Patrick Moran (CFO)
Joakim Wijkstrom (CMO)
Timothy Williams (SVP)
Stephen Ray Mitchell (Director)
Learn More about top insider investors at Vanda Pharmaceuticals.
Who are the major institutional investors of Vanda Pharmaceuticals?: Vanda Pharmaceuticals' top institutional shareholders include:
Renaissance Technologies LLC — 6.61%
Vanguard Group Inc. — 6.01%
Dimensional Fund Advisors LP — 4.27%
Geode Capital Management LLC — 2.49%
Connor Clark & Lunn Investment Management Ltd. — 1.41%
Federated Hermes Inc. — 1.25%
Learn More about top institutional investors of Vanda Pharmaceuticals stock.
Which major investors are selling Vanda Pharmaceuticals stock?: Within the previous quarter, VNDA stock was sold by these institutional investors:
Jacobs Levy Equity Management Inc.
Krensavage Asset Management LLC
D. E. Shaw & Co. Inc.
Bridgeway Capital Management LLC
Renaissance Technologies LLC
Vanguard Group Inc.
ExodusPoint Capital Management LP
Lazard Asset Management LLC
During the previous year, company insiders that have sold Vanda Pharmaceuticals company stock include:
Mihael Hristos Polymeropoulos (CEO)
Kevin Patrick Moran (CFO)
Learn More investors selling Vanda Pharmaceuticals stock.
Which major investors are buying Vanda Pharmaceuticals stock?: Within the last quarter, VNDA stock was purchased by institutional investors including:
Schonfeld Strategic Advisors LLC
Millennium Management LLC
Susquehanna Fundamental Investments LLC
Dimensional Fund Advisors LP
Monaco Asset Management SAM
JPMorgan Chase & Co.
KLP Kapitalforvaltning AS
Norges Bank
In the last year, these company insiders have bought Vanda Pharmaceuticals stock:
Mihael Hristos Polymeropoulos (CEO)
Kevin Patrick Moran (CFO)
Learn More investors buying Vanda Pharmaceuticals stock.